Novo Nordisk A/S
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
Last updated:
Abstract:
The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
Status:
Application
Type:
Utility
Filling date:
6 May 2019
Issue date:
5 Aug 2021